Acumen presents data on pTau217 assay to screen for Phase 2 ALTITUDE-AD trial
PremiumThe FlyAcumen presents data on pTau217 assay to screen for Phase 2 ALTITUDE-AD trial
13d ago
Acumen to deliver late-breaking presentation on ACU193 at CTAD conference
Premium
The Fly
Acumen to deliver late-breaking presentation on ACU193 at CTAD conference
21d ago
Acumen extends collaboration with Lonza
Premium
The Fly
Acumen extends collaboration with Lonza
2M ago
Acumen presents patient experience, biomarker Data from Phase 1 INTERCEPT-AD
PremiumThe FlyAcumen presents patient experience, biomarker Data from Phase 1 INTERCEPT-AD
4M ago
Acumen initiated with a Buy at Citi
Premium
The Fly
Acumen initiated with a Buy at Citi
4M ago
Acumen will present patient experience, data from Phase 1 INTERCEPT-AD study
Premium
The Fly
Acumen will present patient experience, data from Phase 1 INTERCEPT-AD study
4M ago
These 2 ‘Strong Buy’ Penny Stocks Are Poised for Over 300% Gains, Say Analysts
PremiumStock Analysis & IdeasThese 2 ‘Strong Buy’ Penny Stocks Are Poised for Over 300% Gains, Say Analysts
7M ago
Acumen presents first clinical, biomarker data for ACU193
Premium
The Fly
Acumen presents first clinical, biomarker data for ACU193
7M ago
Acumen  teams with Lonza for advancement of sabirnetug to treat AD
Premium
The Fly
Acumen teams with Lonza for advancement of sabirnetug to treat AD
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100